维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="Flatten"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Active oral regimen for elderly adults with newlydiagnosed acute myelogenous leukemi : a preclinical and phase I trial of the famesyltrausferase inhibitor tipifarnib ( R115777, Zameslra ) combined with etoposide 显示文摘	Karp JE Flatten K Feldman E J	2009	Blood2009，113，20：	1
2	Weakly implicit numerical schemes for a two-fluid model显示文摘	Evje S Flatten T	2005	SIAM Journal on Scientific Compu- ting2005，26，5：	1
3	A measureof absorptive capacity: Scale development and valida- tion显示文摘	Flatten T C Engelen A Zahra S A	2011	European Management Journal2011，29，2：	1
4	Phase Ⅲ study by the Norwegian lung cancer study group:pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced Non-small-cell lung cancer显示文摘	Gronberg B H Bremnes R M Flatten O	2009	Journal of Clinical Oncology2009，27，19：	1
5	Hybrid flux-splitting schemes for a common two-fluid flow model 显示文摘	Evje S Flatten T	2003	Jour- nal of Computational Physics2003，192，1：	1
6	The approximate Riemann solver of Roe applied to a drift-flux two- phase flow model显示文摘	Flatten T Munkejord S T	2005	ESAIM: Mathematical Modelling and Numerical Analysis2005，40，4：	1
7	Failure of iniparih to inhibit poly (ADP-Ribose) polymerase in vitro 显示文摘	Patel AG De Lorenzo SB Flatten KS	2012	Clin Cancer Res2012，18，6：	1
8	Failure of iniparib to inhibit poly(ADP-ribose) polymerase in vitro显示文摘	Patel AG De Lorenzo SB Flatten KS		0，，：	1
9	Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia:A preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib(R115777,Zarnestra)combined with etoposide显示文摘	Karp JE Flatten K Feldman EJ	2009	Blood2009，113，20：	1
10	A measure of absorp- tive capacity : Scale development and validation 显示文摘	Flatten TC Engelen A Zabra SA	2011	European Management Journal2011，29，2：	1
11	A measure of absorptive capacity: scale develop- ment and validation显示文摘	FLATTEN T C ENGELEN A ZAHRA S A BRET- TEL M	2011	European Management Journal2011，，29：	1
12	Improving the performance of business models with relationship marketing ef- forts : An entrepreneurial perspective 显示文摘	Brettel M Strese S Flatten T C	2012	European Management Journal2012，30，2：	1
13	A Measure of Absorptive Capacity:Scale Development and Validation显示文摘	Flatten T C Engelen A Zahra S A	2011	European Management Journal2011，29，：	1
14	A measure of absorptive capacity:Scale development and validation显示文摘	FLATTEN T C ENGELEN A ZAHRA S A	2011	European Management Journal2011，29，2：	1
15	A Measure of Absorptive Capacity:Scale Development and Validation显示文摘	Flatten T C Engelen A Zahra S A Brettel M	2011	European Management Journal2011，29，2：	1
16	ATR in- hibition broadly sensitizes ovarian cancer cells to chemotherapy in- dependent of BRCA status显示文摘	Huntoon C J Flatten KS Wahner Hendrickson AE	2013	Cancer Res2013，73，12：	1
17	Depressurization of carbon dioxide in pipelines-models and methods 显示文摘	Lund H Flatten T Munkejord S T	2011	Energy Procedia2011，4，：	1
18	A measure of absorptive capacity: Scale development and validation显示文摘	Tessa C. Flatten Andreas Engelen Shaker A. Zahra Malte Brettel	2010	European Management Journal2010，，2：	1
19	Giving up linearity: absorptive capacity and performance 显示文摘	Brettel Malte Greve Greta I Flatten Tessa C	2011	Journal of Managerial Issues2011，23，2：	1
20	Active oral regimen for elderly adults with newlydiagnosed acute myelogenous leukemi: a preclinical and phase I trial of the famesyltrausferase inhibitor tipifarnib (R115777, Zarneslra) combined with etoposide 显示文摘	Karp JE Flatten K Feldman E J	2009	Blood2009，113，20：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示